The 2022 AABB Virtual Meeting will be Nov. 6-7. Attendees can visit the meeting homepage for details on accessing the virtual platform.

For Donors & Patients
Annual Meeting
- Go
- Schedule
- Learn
- Exhibit
- News
Foundation
AABB Store
Login
My Account
- Welcome, User
- My Profile
- Logout
Search

Membership
- Prospective Members
  - Member Benefits
  - Join AABB
- Current Members
Standards & Accreditation
News & Resources
- News
- Resources
Education
Regulatory & Advocacy
- Regulatory Affairs
- Advocacy
About AABB
- Organization
- Corporate Services
Get Involved

Home
News & Resources
AABB Newsfeed

Newsfeed

AABB's Newsfeed is an essential resource offering the latest news, analysis, commentary and updates on critical topics for the blood and biotherapies community.

AABB is now the Association for the Advancement of Blood & Biotherapies. Learn more about our new name and brand – and watch as we evolve throughout 2022.

Membership
- Prospective Members
  - Member Benefits
  - Join AABB
- Current Members
Standards & Accreditation
News & Resources
- News
- Resources
Education
Regulatory & Advocacy
- Regulatory Affairs
- Advocacy
About AABB
- Organization
- Corporate Services
Get Involved

Privacy Policy | Terms of Use

aabb-wide-footer

4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977

Our Social Media

AABB (Association for the Advancement of Blood & Biotherapies) is an international, not-for-profit organization representing individuals and institutions involved in the fields of transfusion medicine and biotherapies. The Association works collaboratively to advance the field through the development and delivery of standards, accreditation and education programs. AABB is dedicated to its mission of improving lives by making transfusion medicine and biotherapies safe, available and effective worldwide.

©2022 All Rights Reserved. AABB - Association for the Advancement of Blood & Biotherapies

Web Design and Development by Matrix Group International, Inc.